Chih-Ching Wu Selected Research

collapsin response mediator protein-2

4/2008	GSK-3 mediates the okadaic acid-induced modification of collapsin response mediator protein-2 in human SK-N-SH neuroblastoma cells.
1/2008	Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Ching Wu Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 08/2005
13	Squamous Cell Carcinoma of Head and Neck 05/2021 - 05/2011
10	Nasopharyngeal Carcinoma 01/2020 - 08/2005
8	Mouth Neoplasms (Oral Cancer) 01/2022 - 09/2008
8	Lung Neoplasms (Lung Cancer) 02/2020 - 10/2009
7	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021 - 03/2011
7	Pleural Effusion (Pleural Effusions) 01/2021 - 10/2009
7	Schizophrenia (Dementia Praecox) 07/2018 - 11/2016
6	Infections 01/2021 - 04/2015
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 10/2009
5	Neoplasm Metastasis (Metastasis) 09/2017 - 11/2008
5	Urinary Bladder Neoplasms (Bladder Cancer) 09/2015 - 11/2010
4	Inflammation (Inflammations) 06/2021 - 10/2014
4	Malignant Pleural Effusion 01/2021 - 10/2011
3	Carcinoma (Carcinomatosis) 01/2019 - 09/2015
3	Adenocarcinoma of Lung 01/2016 - 10/2009
3	Adenocarcinoma 01/2016 - 05/2011
3	Hernia (Hernias) 06/2013 - 06/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2013 - 03/2003
3	Colorectal Neoplasms (Colorectal Cancer) 02/2012 - 01/2008
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2012
2	Empyema 01/2021 - 06/2019
2	Carcinogenesis 04/2020 - 01/2016
2	Glucosephosphate Dehydrogenase Deficiency 01/2020 - 07/2013
2	Pneumonia (Pneumonitis) 06/2019 - 04/2015
2	Human Influenza (Influenza) 01/2018 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2013 - 01/2011
2	Hematuria 12/2012 - 06/2012
2	Urinary Tract Infections (Urinary Tract Infection) 12/2012 - 06/2012
1	Severe Acute Respiratory Syndrome 01/2022
1	COVID-19 01/2022
1	Respiratory Hypersensitivity 06/2021
1	Asthma (Bronchial Asthma) 06/2021
1	Eosinophilia 06/2021
1	Major Depressive Disorder (Major Depressive Disorders) 07/2020

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
34	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2008
12	ProteomeIBA 01/2019 - 08/2005
6	Tumor Biomarkers (Tumor Markers)IBA 10/2019 - 08/2005
6	Dehydroepiandrosterone (DHEA)IBA 01/2018 - 03/2011
5	Messenger RNA (mRNA)IBA 01/2018 - 12/2008
5	Indicators and Reagents (Reagents)IBA 01/2018 - 05/2013
5	Carrier Proteins (Binding Protein)IBA 11/2012 - 09/2008
4	CytokinesIBA 01/2021 - 05/2011
4	InflammasomesIBA 01/2020 - 11/2012
3	ImmunosorbentsIBA 01/2022 - 01/2017
3	EnzymesIBA 01/2022 - 01/2017
3	Pharmaceutical PreparationsIBA 01/2022 - 09/2019
3	AutoantibodiesIBA 05/2021 - 04/2018
3	ErbB Receptors (EGF Receptor)IBA 12/2020 - 02/2020
3	Biological ProductsIBA 10/2019 - 03/2011
3	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 03/2011
3	PregnenoloneIBA 01/2018 - 01/2017
2	AntibodiesIBA 01/2022 - 08/2014
2	IsotopesIBA 01/2021 - 09/2020
2	Cystine (L-Cystine)IBA 01/2021 - 01/2021
2	ChemokinesIBA 07/2020 - 05/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2019 - 06/2018
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 06/2019 - 01/2017
2	Antipsychotic Agents (Antipsychotics)IBA 07/2018 - 01/2018
2	Pyruvic Acid (Pyruvate)IBA 01/2018 - 11/2016
2	NeurosteroidsIBA 10/2017 - 08/2014
2	MetalsIBA 09/2015 - 03/2013
2	Methylphenidate (Ritalin)FDA LinkGeneric 08/2014 - 09/2011
2	Peptides (Polypeptides)IBA 12/2012 - 06/2012
2	Apolipoprotein A-II (Apolipoprotein A2)IBA 06/2012 - 11/2010
2	Coloring Agents (Dyes)IBA 02/2012 - 09/2008
2	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2011 - 03/2011
2	collapsin response mediator protein-2IBA 04/2008 - 01/2008
1	Neutralizing AntibodiesIBA 01/2022
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	VaccinesIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 06/2021
1	Interleukin-13IBA 06/2021
1	MucinsIBA 06/2021
1	MART-1 AntigenIBA 01/2021
1	GuanosineIBA 01/2021
1	HypoxanthineIBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	phosphorylethanolamine (phosphoethanolamine)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	p-Aminohippuric Acid (p-Aminohippurate)FDA Link 01/2021
1	AcidsIBA 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	Long Noncoding RNAIBA 01/2021
1	2,5-dihydroxybenzoic acid (gentisic acid)IBA 01/2021
1	Fenofibrate (CiL)FDA LinkGeneric 01/2021
1	HydroxylysineIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 12/2020
1	DipeptidesIBA 09/2020
1	Interleukin-8 (Interleukin 8)IBA 09/2020
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 04/2020
1	hydroxygenkwaninIBA 02/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	SynucleinsIBA 11/2019
1	PolyaminesIBA 03/2019

Therapy/Procedure

2	Therapeutics 01/2022 - 06/2014
1	Precision Medicine 01/2022